Skip to content

Author

Lale Maulin Prihatina

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Insulin Enhances the Viability of Doxorubicin-Exposed Luminal A Breast Cancer T-47D Cells

Breast cancer is one of the most common cancers worldwide, with a high incidence rate. Doxorubicin is a chemotherapeutic agent used in breast cancer management. Nevertheless, chemoresistance remains a major challenge in breast cancer chemotherapy. Insulin contributes to chemoresistance through its mitogenic and prosurv...

Fadhilla Resendryana Esthya, Novrita Padauleng, Lale Maulin Prihatina · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.